Characterization of 28 unknown impurities in 16-membered macrolides by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry

被引:10
作者
Liu, Guijun [1 ]
Zhu, Bingqi [2 ]
Ren, Xiaojuan [1 ]
Wang, Jian [1 ,3 ]
机构
[1] Zhejiang Univ Technol, Hangzhou 310014, Peoples R China
[2] Zhejiang Chinese Med Univ, Hangzhou 310053, Peoples R China
[3] Zhejiang Inst Food & Drug Control, Key Lab Core Technol Gener Drug Evaluat Natl Med, Hangzhou 310052, Peoples R China
关键词
Josamycin; Midecamycin; Meleumycin; Impurity; 16-Membered macrolides; Ion trap/time-of-flight mass spectrometry; COMPONENTS; IDENTIFICATION; ANTIBIOTICS;
D O I
10.1016/j.jpba.2020.113324
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In terms of risk assessment, the study of the impurity profile is important to ensure the safety and effectiveness of drugs in clinical application. Sixteen-membered macrolides are produced by microbial fermentation, and many closely related substances in the product make the components and impurities complicated. In this study, methods were developed to separate and identify the impurities in three representative 16-membered macrolides (josamycin, midecamycin and meleumycin) using a high-performance liquid chromatography coupled to high-resolution ion trap/time-of-flight mass spectrometry (IT-TOF MS). In total, 53 impurities were characterized in the positive mode of electrospray ionization, among which 28 novel impurities were found. The proposed structures of impurities were deduced based on MS/MS data, and the ultraviolet (UV) absorption behaviors of impurities were discussed. In addition to the impurities with maximum absorption wavelengths (lambda(max)) of 231 nm and 280 nm, there was a new group of impurities with lambda(max) of 205 nm in meleumycin, midecamycin and josamycin. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:11
相关论文
共 19 条
[1]  
[Anonymous], 2016, The Japanese Pharmacopoeia, V17th
[2]  
[Anonymous], 2015, PHARM PEOPL REP CHIN
[3]  
[Anonymous], [No title captured]
[4]   16-membered macrolide antibiotics: a review [J].
Arsic, Biljana ;
Barber, Jill ;
Cikos, Ana ;
Mladenovic, Milan ;
Stankovic, Nevena ;
Novak, Predrag .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (03) :283-298
[5]   N′-Substituted-2′-O,3′-N-carbonimidoyl Bridged Macrolides: Novel Anti-inflammatory Macrolides without Antimicrobial Activity [J].
Bosnar, Martina ;
Kragol, Goran ;
Kostrun, Sanja ;
Vujasinovic, Ines ;
Bosnjak, Berislav ;
Mihaljevic, Vlatka Bencetic ;
Istuk, Zorica Marusic ;
Kapic, Samra ;
Hrvacic, Boska ;
Brajsa, Karmen ;
Tavcar, Branka ;
Jelic, Dubravko ;
Glojnaric, Ines ;
Verbanac, Donatella ;
Culic, Ognjen ;
Padovan, Jasna ;
Alihodzic, Sulejman ;
Haber, Vesna Erakovic ;
Spaventi, Radan .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) :6111-6123
[6]  
Commissioner, 2012, COMMISSIONER KOREA F
[7]   Identification of the components of 16-membered macrolide antibiotics by LC/MS [J].
Hu, M ;
Hu, CQ .
ANALYTICA CHIMICA ACTA, 2005, 535 (1-2) :89-99
[8]   Characterization of a new component and impurities in josamycin by trap-free two-dimensional liquid chromatography coupled to ion trap time-of-flight mass spectrometry [J].
Liu, Guijun ;
Xu, Yu ;
Sang, Jing ;
Zhu, Bingqi ;
Wang, Jian .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2019, 33 (12) :1058-1066
[9]  
Liu Y, 2003, CHROMATOGRAPHIA, V57, P143
[10]   Modifications and Biological Activity of Natural and Semisynthetic 16-Membered Macrolide Antibiotics [J].
Przybylski, Piotr .
CURRENT ORGANIC CHEMISTRY, 2011, 15 (03) :328-374